AFYREN announces signing of new commercial contract with US nutraceutical manufacturer

Regulatory News:

AFYREN (Paris:ALAFY), a greentech company that offers producers bio-based, low-carbon ingredients produced using a unique fermentation technology based on a fully circular model, has signed a commercial contract with a US manufacturer of nutraceutical ingredients.

AFYREN has signed a new multi-year contract with a US company specializing in nutraceutical ingredients and solutions, a fast-growing, high-value market where food and pharma meet. Under the multi-year contract, AFYREN will supply its bio-based acids to the customer, an ingredient and solution provider, for applications such as preservatives and flavors for dietary supplements. The multi-billion dollar nutraceuticals market is expected to grow by high single digits in the coming years, driven by consumer demand for products that can improve their overall health and well-being, with a focus on natural and sustainable ingredients.¹.